1-(4-fluorophenyl)-5-[4-(methylsulfonyl)phenyl]-pyrazole-3-carbonitrile;COX-2-IN-2;1H-Pyrazole-3-carbonitrile, 1-(4-fluorophenyl)-5-[4-(methylsulfonyl)phenyl]-;COX2IN2,COX 2 IN 2;COX-2-IN-2, 10 mM in DMSO
COX-2-IN-2 is a selective and inducible COX-2 inhibitor with anti-inflammatory and analgesic activities; it exhibits potent efficacy in models of adjuvant-induced arthritis (oral ED50 = 0.030 mg/kg) and collagen-induced arthritis (oral ED50 = 0.47 mg/kg), as well as significant analgesic activity in the yeast-induced hyperalgesia (Randall-Selitto) assay (ED30 = 7.4 mg/kg); notably, it shows no ulcerogenicity.